2-amino-9-[(2R,3S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-hydroxy-6,9-dihydro(2-13C,1-15N)-1H-purin-6-one

• ChemBase编号: 170630
• 分子式: C10H13N5O6
• 平均质量: 302.21959263
• 单一同位素质量: 302.08400779
• SMILES: [C@@H]1(C([C@H](O[C@H]1n1c2c(nc1O)c(=O)[15nH][13c](n2)[15NH2])CO)O)O
• Canonical SMILES: OC[C@H]1O[C@H]([C@H](C1O)O)n1c(O)nc2c1n[13c]([15NH2])[15nH]c2=O
• InChI: InChI=1S/C10H13N5O6/c11-9-13-6-3(7(19)14-9)12-10(20)15(6)8-5(18)4(17)2(1-16)21-8/h2,4-5,8,16-18H,1H2,(H,12,20)(H3,11,13,14,19)/t2-,4?,5+,8-/m1/s1/i9+1,11+1,14+1
• InChIKey: FPGSEBKFEJEOSA-NINVBBQRSA-N

名称和登记号

名称

• IUPAC标准名: 2-amino-9-[(2R,3S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-hydroxy-6,9-dihydro(2-^1^3C,1-^1^5N)-1H-purin-6-one
• IUPAC传统名: 2-amino-9-[(2R,3S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-hydroxy(2-^1^3C,1-^1^5N)-1H-purin-6-one
• 别名: 2-Amino-9-β-D-ribofuranosyl-purine-6,8(1H,9H)-dione-13C,15N2; 8-OHG-13C,15N2; 8-Oxo-7,8-dihydroguanosine-13C,15N2; 8-Oxoguanosine-13C,15N2; NSC 90393-13C,15N2; 8-Hydroxy Guanosine-13C,15N2

登记号

• PubChem SID: 164226540
• PubChem CID: 71749064

理论计算性质

• Acid pKa: 10.084022
• 质子受体: 9
• 质子供体: 6
• LogD (pH = 5.5): -2.325589
• LogD (pH = 7.4): -2.3263319
• Log P: -2.3255336
• 摩尔折射率: 66.0753 cm^3
• 极化性: 25.036772 Å^3
• 极化表面积: 175.45 Å^2
• 可自由旋转的化学键: 2
• 里宾斯基五规则: false

分子性质

理化性质

• 溶解度: DMSO; Methanol
• 外观: Off-White Solid
• 熔点: 235-240°C

安全信息

• 保存条件: -20°C Freezer

详细说明

Toronto Research Chemicals - H942772

Labelled 8-Hydroxy Guanosine (H942770). It is a representative metabolite derived by the oxidation of Guanosine (G) and is regarded as a marker of oxidative stress in the cells.

参考文献

• Lin, T.-S. et al.: J. Med. Chem., 28, 1194 (1985)
• Risom, L., et al.: Mutat. Res., 592, 119 (1985)
• Knaapen, A., et al.: Mutagenesis, 21, 225 (1985)